HIDRADENITIS SUPPURATIVA

This study tested whether a medicine called spesolimab helps adults with moderate to severe hidradenitis suppurativa, a chronic skin condition that causes painful lumps and boils. Participants were randomly assigned to receive either spesolimab or a placebo (dummy treatment) as i…

This large, completed Phase 3 trial tested whether an injectable medication called bimekizumab could help people with moderate to severe hidradenitis suppurativa (HS), a chronic skin condition that causes painful lumps under the skin. Over 500 participants received either the dru…

This study tested whether a drug called spesolimab helps adults with moderate to severe hidradenitis suppurativa (HS), a chronic skin condition that causes painful lumps and tunnels under the skin. Over 200 participants received either spesolimab injections or a placebo (dummy tr…

This study tested an experimental drug called SAR442970 for adults with moderate-to-severe hidradenitis suppurativa (HS), a chronic skin condition causing painful lumps and tunnels under the skin. The main goal was to see if the drug was better than a placebo (a dummy shot withou…

This study followed adults with hidradenitis suppurativa (HS) for about two years to see if a medicine called spesolimab is safe and effective for long-term use. Participants received injections every two weeks, and doctors tracked their skin symptoms and any side effects. The go…

This study tested whether a new drug called imsidolimab could reduce painful lumps and sores in people with hidradenitis suppurativa (HS), a chronic inflammatory skin disease. 149 adult participants with moderate to severe HS were randomly assigned to receive either the drug or a…

This study tested whether the drug tofacitinib is safe and effective for treating several common autoimmune skin conditions in adolescents and adults with Down syndrome. Researchers wanted to see if reducing overactive immune signaling could improve skin health, quality of life, …

This study tested an experimental drug called ATI-450 against a placebo in 95 people with moderate to severe hidradenitis suppurativa, a painful skin condition. Researchers wanted to see if ATI-450 could reduce the number of painful skin lumps and improve patients' quality of lif…

This completed Phase 3 trial tested whether the drug bimekizumab could reduce painful skin lesions and improve quality of life for people with moderate to severe hidradenitis suppurativa (HS), a chronic inflammatory skin disease. The study involved 505 adults whose HS did not res…

This study looked at whether switching patients to a higher concentration version of the drug adalimumab (brand name SIMLANDI™) causes less injection site pain than the standard version. It involved 324 adults in Canada who were already using adalimumab for conditions like Crohn'…

This study tested whether mindfulness training could improve the quality of life for people with hidradenitis suppurativa (HS), a painful and chronic skin condition. Researchers enrolled 37 HS patients to see if learning mindfulness techniques could help them better manage pain, …

This small study tested whether a special bioelectric dressing could help skin heal better after surgery for hidradenitis suppurativa (HS), a painful skin condition. Researchers enrolled 12 adults with HS to see if the dressing could speed up healing, reduce pain, and improve sca…

This study aimed to understand the specific inflammatory processes that drive hidradenitis suppurativa (HS), a chronic skin condition. Researchers analyzed small skin samples from 20 people with HS who were having surgery, comparing them to samples from people without the disease…

This study aimed to better understand how Hidradenitis Suppurativa (HS), a painful and chronic skin condition, affects people's daily lives, mental health, and social well-being. Researchers surveyed 67 adults diagnosed with HS to measure its impact and test a simple photo-based …